Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Omicron variant of concern: Diversification and convergent evolution in spike protein, and escape from anti-Spike monoclonal antibodies
Daniele Focosi, Scott A. McConnell, Arturo Casadevall
Drug Resistance Updates (2022) Vol. 65, pp. 100882-100882
Open Access | Times Cited: 40

Showing 1-25 of 40 citing articles:

Genome‐based comparison between the recombinant SARS‐CoV‐2 XBB and its parental lineages
Fabio Scarpa, Daria Sanna, Ilenia Azzena, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 3
Open Access | Times Cited: 35
Evolving Real-World Effectiveness of Monoclonal Antibodies for Treatment of COVID-19
Kevin E. Kip, Erin K McCreary, Kevin Collins, et al.
Annals of Internal Medicine (2023) Vol. 176, Iss. 4, pp. 496-504
Open Access | Times Cited: 29
Cationic crosslinked carbon dots-adjuvanted intranasal vaccine induces protective immunity against Omicron-included SARS-CoV-2 variants
Lei Hong, Aqu Alu, H. J. Yang, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 20
An update on the anti-spike monoclonal antibody pipeline for SARS-CoV-2
Daniele Focosi, Massimo Franchini, Arturo Casadevall, et al.
Clinical Microbiology and Infection (2024) Vol. 30, Iss. 8, pp. 999-1006
Closed Access | Times Cited: 9
Discovery of novel papain-like protease inhibitors for potential treatment of COVID-19
Fatema Hersi, Anusha Sebastian, Hamadeh Tarazi, et al.
European Journal of Medicinal Chemistry (2023) Vol. 254, pp. 115380-115380
Open Access | Times Cited: 16
Comparative Review of the State of the Art in Research on the Porcine Epidemic Diarrhea Virus and SARS-CoV-2, Scope of Knowledge between Coronaviruses
Nora Hilda Rosas-Murrieta, Alan Rodríguez-Enríquez, Irma Herrera‐Camacho, et al.
Viruses (2024) Vol. 16, Iss. 2, pp. 238-238
Open Access | Times Cited: 4
SARS-CoV-2 Omicron: Viral Evolution, Immune Evasion, and Alternative Durable Therapeutic Strategies
Hailong Guo, Sha Ha, Jason Botten, et al.
Viruses (2024) Vol. 16, Iss. 5, pp. 697-697
Open Access | Times Cited: 3
Subsequent Waves of Convergent Evolution in SARS-CoV-2 Genes and Proteins
Daniele Focosi, Pietro Giorgio Spezia, Fabrizio Maggi
Vaccines (2024) Vol. 12, Iss. 8, pp. 887-887
Open Access | Times Cited: 3
Genetic and structural analyses reveal the low potential of the SARS‐CoV‐2 EG.5 variant
Fabio Scarpa, Stefano Pascarella, Alessandra Ciccozzi, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 9
Open Access | Times Cited: 10
Antibody evasion associated with the RBD significant mutations in several emerging SARS-CoV-2 variants and its subvariants
Manojit Bhattacharya, Srijan Chatterjee, Sang‐Soo Lee, et al.
Drug Resistance Updates (2023) Vol. 71, pp. 101008-101008
Closed Access | Times Cited: 8
Multiple mutations of SARS-CoV-2 Omicron BA.2 variant orchestrate its virological characteristics
Izumi Kimura, Daichi Yamasoba, Hesham Nasser, et al.
Journal of Virology (2023) Vol. 97, Iss. 10
Open Access | Times Cited: 8
Antibody drugs targeting SARS-CoV-2: Time for a rethink?
Likeng Liang, Bo Wang, Qing Zhang, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 176, pp. 116900-116900
Open Access | Times Cited: 2
Whole‐genome single molecule real‐time sequencing of SARS‐CoV‐2 Omicron
Florence Nicot, Pauline Trémeaux, Justine Latour, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 2
Open Access | Times Cited: 7
New star-shaped ligands generated by evolutionary fitting the Omicron spike inner-cavity
Julio Coll
(2023)
Open Access | Times Cited: 7
SARS-CoV-2 Recombinants: Genomic Comparison between XBF and Its Parental Lineages
Fabio Scarpa, Chiara Locci, Ilenia Azzena, et al.
Microorganisms (2023) Vol. 11, Iss. 7, pp. 1824-1824
Open Access | Times Cited: 7
SARS-CoV-2 BW lineage, a fast-growing Omicron variant from southeast Mexico bearing relevant escape mutations
Rodrigo García-López, Xaira Rivera-Gutiérrez, Mauricio Rosales-Rivera, et al.
Infection (2023) Vol. 51, Iss. 5, pp. 1549-1555
Open Access | Times Cited: 6
Mosaic Recombination Inflicted Various SARS-CoV-2 Lineages to Emerge into Novel Virus Variants: a Review Update
Pushpendra Singh, Kuldeep Sharma, Dipika Shaw, et al.
Indian Journal of Clinical Biochemistry (2022) Vol. 38, Iss. 4, pp. 418-425
Open Access | Times Cited: 10
Epidemiological Surveillance Reveals the Rise and Establishment of the Omicron SARS-CoV-2 Variant in Brazil
Joice do Prado Silva, Aline Brito de Lima, Luige Biciati Alvim, et al.
Viruses (2023) Vol. 15, Iss. 4, pp. 1017-1017
Open Access | Times Cited: 5
Genomic Surveillance of SARS-CoV-2 in Malaysia during the Era of Endemic COVID-19
Tze Yan Lee, Wai Feng Lim, Geik Yong Ang, et al.
Life (2023) Vol. 13, Iss. 8, pp. 1644-1644
Open Access | Times Cited: 5
Efficacy of convalescent plasma in hospitalized COVID-19 patients: findings from a controlled trial
Tânia Portella Costa, Mateus Nóbrega Aoki, Camilla Moreira Ribeiro, et al.
Brazilian Journal of Medical and Biological Research (2024) Vol. 57
Open Access | Times Cited: 1
Heterologous mRNA vaccine boosters induce a stronger and longer-lasting antibody response against Omicron XBB variant
Matthew Zirui Tay, Yun Shan Goh, Siew‐Wai Fong, et al.
The Lancet Regional Health - Western Pacific (2023) Vol. 33, pp. 100732-100732
Open Access | Times Cited: 4
Digital PCR Discriminates between SARS-CoV-2 Omicron Variants and Immune Escape Mutations
Steven C. Holland, LaRinda A. Holland, Matthew F. Smith, et al.
Microbiology Spectrum (2023) Vol. 11, Iss. 4
Open Access | Times Cited: 4
Facing the Challenges in the COVID-19 Pandemic Era: From Standard Treatments to the Umbilical Cord-Derived Mesenchymal Stromal Cells as a New Therapeutic Strategy
Eleonora Russo, Simona Corrao, Francesca Di Gaudio, et al.
Cells (2023) Vol. 12, Iss. 12, pp. 1664-1664
Open Access | Times Cited: 4
COVID-19: Understanding the New Variants of Concern
Ke-Yan Loo, Vengadesh Letchumanan
Progress In Microbes & Molecular Biology (2022) Vol. 5, Iss. 1
Open Access | Times Cited: 8
Predictors of high SARS-CoV-2 immunoglobulin G titers in COVID-19 convalescent whole-blood donors: a cross-sectional study in China
Jingyun Tang, Humin Liu, Qing Wang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top